This inventor holds 1 USPTO granted patent. Top assignee: Cosejo Superior De Invetigaciones Certificas. Active years: 1993.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1993
Title: The Innovative Contributions of Gregorio Alvaro Campos
Introduction
Gregorio Alvaro Campos is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the synthesis of semi-synthetic antibiotics. His work is characterized by a focus on thermodynamically controlled strategies that enhance the efficiency of antibiotic production.
Latest Patents
Gregorio holds a patent for a method that involves the synthesis of semi-synthetic monobactamic or β-Lactamic antibiotics. This innovative method utilizes derivatives stabilized by various methods of penicillin G acylase from different microbial sources. The process is conducted in monophase water/cosolvent organic apolar systems, with specific parameters for cosolvent concentration, temperature, pH, and antibiotic nucleus concentrations. His patent is particularly relevant to the pharmaceutical industry, showcasing his commitment to advancing medical science.
Career Highlights
Gregorio is affiliated with the Consejo Superior de Investigaciones Científicas, a prestigious research institution in Spain. His work has not only contributed to the scientific community but has also paved the way for advancements in antibiotic synthesis. With a patent count of 1 patent, he exemplifies the impact that a single innovative idea can have on the industry.
Collaborations
Throughout his career, Gregorio has collaborated with esteemed colleagues such as Jose Manuel Guisan Seijas and Roberto Fernandez Lafuente. These partnerships have enriched his research and expanded the scope of his work in antibiotic synthesis.
Conclusion
Gregorio Alvaro Campos stands out as a significant figure in the field of pharmaceutical innovation. His patented method for synthesizing semi-synthetic antibiotics demonstrates his dedication to improving healthcare solutions. His contributions continue to influence the pharmaceutical industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile